1312PDEverolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study. (23rd October 2018) - Walter, T; Lepage, C; Coriat, R; Barbier, E; Cadiot, G; Caroli Bosc, F X; Aparicio, T; Bouhier Leporrier, K; Hentic Dhome, O; Dupont-Gossart, A-C; Duluc, M; Lepere, C; et al.